Merck & Co.
The drug — a new form of immunotherapy — is called Keytruda. And it’s being called a gamechanger in the field of cancer treatment.
A Merck spokeswoman says the layoffs will take effect between December 23rd and January 5th at its West Point facility.
Drugmaker Merck says it plans to reduce its global workforce by another 8,500 jobs as part of a plan to cut its annual costs by about $2.5 billion by the end of 2015.
Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its second application to sell a new type of allergy treatment meant to gradually reduce allergic reactions over time, rather than just relieving sneezing, itching and other symptoms temporarily.
“It’s like one of the best art collections in the world that has been kept privately and now it’s going to be made available,” says Dr. Tim Block, founder and president of the Hepatitis B Foundation.